Market Intelligence

Access the latest earnings reports, market analysis, hot topics, and individual stock insights

Report Categories

View All

Recent Articles

View All
Nvmi Stock Under Pressure On Earnings News 20260403 1 Technology Select Sector SPDR Fund XLK Core Holding Oracle ORCL Secures Strong Bullish Consensus Amid Cloud Growth Momentum GRC GormanRupp posts 282 percent EPS beat over analyst estimates for Q1 2026 shares climb 324 percent How Krystal Biotech KRYS earnings power compares to its price 270 20260508 MMTXU Miluna acquisition Corp Units report no quarterly earnings data available shares unchanged Kevin Warsh Set to Assume Federal Reserve Chairmanship in White House Ceremony Cheniere Reports Strong Q1 2026 Results Raises FullYear Guidance Morrisons to Close 100 Stores Amid Rising Cost Pressures Sensex Dips 142 Points Nifty Holds Above 23900 as Mid and SmallCaps Shine Nvidia Stock at Critical Juncture Key Technical Level Could Determine Next Move Zscaler Stock Plunges Over 30 After Disappointing Revenue Outlook GREEL Q1 2025 Earnings Narrower Loss Surpasses Estimates as Senior Notes Remain Stable SION Q1 2026 Earnings WiderThanExpected Loss as PreRevenue Biotech Advances Pipeline NextPlat Corp NXPL Q1 2026 Earnings Loss per share of 042 stock edges up 155 amid limited disclosure LAR Q1 2026 Earnings Lithium Developer Misses EPS Estimates Shares Slide on Earnings Miss FBIO Q4 2025 Earnings Deep EPS Miss Highlights Challenges for PreRevenue Biotech SBLK Q1 2026 Earnings Strong Beat on EPS as Dry Bulk Market Improves Nuveen Core Equity Alpha Fund JCE Inches Higher Near Key Resistance Level Tevogen Bio Holdings Warrant TVGNW Stalls at 004 as Trading Remains Flat ZOOZ Strategy Ltd Warrant ZOOZW Surges 5789 as Speculative Interest Builds JELDWEN Holding JELD Edges Higher Approaching Key Resistance Level Bank of the James Financial Group Inc BOTJ Edges Lower Amid Light Trading Support Levels in Focus TrueBlue Q1 2026 Earnings EPS Surprises with 979 Beat Amid Labor Market Uncertainty SEER Q1 2026 Earnings Slight EPS Beat Amidst Quiet Revenue Disclosure SPRB Q1 2026 Earnings NarrowerthanExpected Loss Fails to Lift Shares as Pipeline Progress Remains Key MoonLake Immunotherapeutics MLTX Q1 2026 Earnings EPS Misses Estimates as ClinicalStage Biotech Advances Pipeline SPIR Q1 2026 Earnings Earnings Miss Meets Positive Stock Reaction Amid Strategic Shifts Curis Inc Q1 2026 Earnings Deep EPS Miss as PreRevenue Biotech Continues Development